logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Enalapril CAS 75847-73-3

Enalapril CAS 75847-73-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 75847-73-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
75847-73-3
Appearance::
Powder
Molecular Formula::
C20H28N2O5
Molecular Weight::
376.44700
EINECS NO::
278-375-7
MDL NO::
MFCD00865774
CAS NO::
75847-73-3
Appearance::
Powder
Molecular Formula::
C20H28N2O5
Molecular Weight::
376.44700
EINECS NO::
278-375-7
MDL NO::
MFCD00865774
Enalapril CAS 75847-73-3

Product Description:

Product Name: Enalapril CAS NO: 75847-73-3

 

 

Synonyms:

N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-L-proline;

Eletriptan [INN:BAN];

[3H]-Eletriptan;

 

 

Chemical & Physical Properties:

Appearance: Powder

Assay :≥99.0%

Density: 1.204g/cm3

Boiling Point: 582.4℃ at 760 mmHg

Melting Point: 143-144.5℃

Flash Point: 306℃

Refractive Index: 1.549

Storage Condition: Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.

 

 

Safety Information:

Safety Statements: S22-S24/25

Hazard Declaration: H317; H361

Signal Word: Warning

Caution Statement: P280

Symbol: GHS07, GHS08

 

 

Enalapril (marketed as Vasotec in the US, Enaladex and Renitec in some other countries, and Enacard for veterinary use:142–143) is an angiotensin-converting-enzyme (ACE) inhibitor used in the treatment of hypertension, diabetic nephropathy, and some types of chronic heart failure.

ACE converts the peptide hormone angiotensin I to angiotensin II. One of the actions of angiotensin II is the vasoconstriction of blood vessels, resulting in an increase in blood pressure. ACE inhibitors such as enalapril prevent this effect. Enalapril has been shown to lower the death rate in systolic heart failure.

It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.